ERA4Health

What ERA4Health does

ERA4Health is a European research partnership established in 2022 and coordinated by Instituto de Salud Carlos III (ISCIII) in Madrid, Spain, operating under the EU Horizon Europe Framework Programme (Grant Agreement No. 101095426). It functions as a transnational funding coordination mechanism rather than a commercial enterprise: the consortium unites ministries, national and regional funding agencies, research institutes and foundations — reported as 33 partners and 27 funding organisations across 22 countries on the homepage, and as 67 entities from 30 countries in broader programme data — to pool resources for joint transnational calls in priority health areas including cardiovascular disease, nutrition and lifestyle-related diseases, nanomedicine, health equity, and investigator-initiated clinical studies (IICS).

The partnership's core operational outputs are Joint Transnational Calls (JTCs) and the EffecTrial IICS track, with six calls published to date (CardInnov 2023, HealthEquity 2023, NutriBrain 2024, NanoTecMec 2024, InterHeart 2025, EffecTrial 2025) and two further calls announced for 2026 (Trials4Health 2026, Prevent-OO 2026). Across these, €66M has been committed to 76 funded projects supporting 140 research teams. Underlying these calls is a web-based consortium infrastructure comprising the ptoutline.eu electronic proposal submission platform, the PARTFINDER partner-search tool, a project monitoring tool, and a publicly accessible deliverables library. Supporting capacity-building services include an ERA4Health webinar series, an Early Career Network, IICS-recommended training, and recommended lectures.

ERA4Health does not generate commercial revenue. All funding flows from the EU Horizon Europe co-funding arrangement and contributions from national/regional funding organisation partners into research consortia. The partnership generates no traditional pricing or sales motion; instead, its "go-to-market" is the open call process — proposals are submitted via a dedicated platform and evaluated in a two-stage process with a rebuttal stage. The headcount of 11-50 supports coordination, management, and the Strategic Advisory Board and Ethics and RRI Advisory Board governance functions. Quantifiable non-financial KPIs show substantial engagement growth: LinkedIn followers +300% (1,000 to 2,998), YouTube views +163% (2,000 to 3,255), and website visits +236% (45,000 to 106,310) over the course of the initiative.

Name

ERA4Health

Legal name

ERA4Health Partnership

Website

https://era4health.eu

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

ERA4Health is a Horizon Europe co-funded European research partnership coordinated by ISCIII in Madrid, pooling 67 entities across 30 countries to fund transnational collaborative health research through joint calls covering cardiovascular, nutrition, nanomedicine and clinical studies.

Ownership category

akta.pro rank

Product category

Health Research Funding Coordination

NAICS

Scientific Research and Development Services (5417), Voluntary Health Organizations (813212)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Membership Organizations (8600), Services-Health Services (8000)

akta.pro primary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

akta.pro secondary industry

Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB)

Keywords

• Transnational health research
• Joint research funding
• Clinical research coordination
• Public health partnership
• Investigator-initiated clinical studies

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. EU Horizon Europe Grant: ERA4Health is co-funded by the European Union under the Horizon Europe Framework Programme (Grant Agreement No. 101095426). This constitutes the primary public funding mechanism supporting the partnership's operations and joint transnational call activities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

ERA4Health coordinates and funds transnational collaborative health research across Europe through Joint Transnational Calls (JTCs) for proposals in priority areas including cardiovascular diseases, nutrition and lifestyle-related diseases, nanomedicine, health equity, and investigator-initiated clinical studies (IICS). The partnership is co-funded by the European Union under Horizon Europe and distributes funding through national funding organisations to research consortia across 30 countries, while supporting coordination via partner search tools, project monitoring, and capacity-building programmes.

Product overview

ERA4Health is a European partnership fostering health research through funding programs. The core offering consists of Joint Transnational Calls (JTCs) funding collaborative research across cardiovascular diseases, nutrition, nanomedicine, and obesity. Supporting services include the PARTFINDER partner search platform for consortium building, a Monitoring Tool for project tracking, a Deliverables Library for research outputs, webinars on health research topics including AI in healthcare, and an Early Career Network for researcher development. The partnership maintains a Funded Projects Database of 76 projects. ERA4Health functions as a funding coordination body rather than a traditional product company.

Differentiator

Problem solved

Functional benefit

Products and services

• Joint Transnational Calls (JTCs) Funding mechanisms for transnational collaborative research projects addressing European public health needs. Includes themed calls on cardiovascular diseases (CardInnov, InterHeart), nutrition and brain health (NutriBrain), nanomedicine (NanoTecMec), health equity and physical activity (HealthEquity), obesity prevention (Prevent-OO), and investigator-initiated clinical studies (EffecTrial, Trials4Health). Targeted at academic researchers, clinicians, and research institutions across Europe and partner countries.
• PARTFINDER Partner Search Tool Online platform enabling research groups to find partners and establish consortia for ERA4Health calls and other joint transnational research competitions. Targeted at research teams preparing collaborative proposals for EU-level funding calls.
• Monitoring Tool Platform for coordinators of funded projects to collect indicators and outcomes, coordinate monitoring, evaluate results, and assess consistency with partnership objectives. Targeted at project coordinators of ERA4Health-funded research projects.
• Deliverables Library Public access to project deliverables including call documents, ranking lists, reports on IICS bottlenecks, RRI guidelines, and consortium outputs. Provides 29 public deliverables including clinical trial recommendation booklets and data-sharing guidelines for investigator-initiated clinical studies.
• ERA4Health Webinars Series of webinars covering thematic areas including AI in healthcare, pragmatic clinical trials, cardiovascular disease research, and responsible innovation. Designed to enhance capacity building, provide new knowledge and insights, and keep participants updated on developments in health research. The 10th webinar covered how AI enables improved medical practice and clinical research (May 2026).
• Early Career Network Network fostering interaction, capacity and growth of Early Career Researchers (ECR) involved in ERA4Health-funded projects. Includes face-to-face meetings (e.g., 2nd meeting in Brussels, March 2026) and ongoing community engagement activities.
• Funded Projects Database Comprehensive database of all 76 funded projects organized by call, including project abstracts, coordinators, and participating institutions.

Quantifiable outcome

• €66M invested across 76 funded projects involving 140 research teams from 30 countries
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Partnerships

13 partnerships are on record, tiered core.

• BioMed AlliancecoreStrategic or Co-development PartnerBioMed Alliance is a member of the ERA4Health Strategic Advisory Board (STAB), providing strategic advice on topics including Prevention and Public Health strategies, Nutrition and Lifestyles related-diseases, Cardiovascular Diseases, Nano and other advanced health technologies, and Investigator Initiated Clinical Studies (IICS). Representative: Wilfried Ellmeier.
• EFPIA (European Federation of Pharmaceutical Industries and Associations)coreStrategic or Co-development PartnerEFPIA is a member of the ERA4Health Strategic Advisory Board (STAB), contributing pharmaceutical industry expertise and strategic guidance on health research priorities. Representative: Matthias Mullenborn.
• EHN – European Heart NetworkcoreStrategic or Co-development PartnerEHN is a member of the ERA4Health STAB, providing expertise in cardiovascular health and patient advocacy perspectives. Representative: Birgit Beger.
• ESC – European Society of CardiologycoreStrategic or Co-development PartnerESC is a member of the ERA4Health STAB, providing scientific and clinical expertise in cardiology. Representative: Hugo Katus.
• EUHA – European University Hospital AlliancecoreStrategic or Co-development PartnerEUHA is a member of the ERA4Health STAB, contributing academic hospital expertise to the partnership's strategic direction. Representative: Lynn Seveke.
• EUPATI – European Patients Academy on Therapeutic InnovationcoreStrategic or Co-development PartnerEUPATI is a member of the ERA4Health STAB and serves as Chair of the STAB, providing patient-centered perspectives on therapeutic innovation. Representative: Richard Ballerand (Chair).
• EuroHealthNet – European Partnership for Health, Equity and WellbeingcoreStrategic or Co-development PartnerEuroHealthNet is a member of the ERA4Health STAB, contributing expertise on health equity and public health. Representative: Caroline Costongs.
• FENS – Federation of European Nutrition SocietiescoreStrategic or Co-development PartnerFENS is a member of the ERA4Health STAB and serves as Vice-chair, providing nutritional science expertise. Representative: Philip Calder (Vice-chair).
• ISBNPA – International Society of Behavioral Nutrition and Physical ActivitycoreStrategic or Co-development PartnerISBNPA is a member of the ERA4Health STAB, providing expertise in behavioral nutrition and physical activity research. Representative: Antonio Labisa Palmeira.
• MedTech EuropecoreStrategic or Co-development PartnerMedTech Europe is a member of the ERA4Health STAB, contributing medical technology industry perspective. Representative: Jeroen Scheurmans.
• ECRIN (European Clinical Research Infrastructure Network)coreStrategic or Co-development PartnerECRIN is a consortium partner and not-for-profit intergovernmental organisation. It provides infrastructure and expertise for multinational clinical studies, hosting workshops on IICS funding mechanisms and producing guidance documents for ERA4Health. ECRIN authored key deliverables including reports on bottlenecks for multicountry IICS and recommendation booklets for investigators.
• ISCIII (Instituto de Salud Carlos III)coreStrategic or Co-development PartnerISCIII serves as the Coordinator of the ERA4Health Partnership, located in Madrid, Spain. It leads the Management Board and overall partnership coordination, including Joint Call Secretariats.
• National and Regional Funding Agencies (67 entities from 30 countries)coreStrategic or Co-development PartnerThe consortium includes 67 entities from 30 countries, comprising ministries, national and regional funding agencies such as ANR (France), FWF (Austria), SNSF (Switzerland), DLR (Germany), NKFIH (Hungary), RCN (Norway), NCBR (Poland), FCT (Portugal), TUBITAK (Turkey), NSTC (Taiwan), and many others. These entities provide national funding for joint transnational calls.

Scale indicators9 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Global Alliance for Chronic Diseases (GACD): International alliance of public research funders coordinating joint calls on chronic diseases. Operates a similar transnational joint-call mechanism overlapping ERA4Health's cardiovascular and nutrition portfolio.
• European Partnership on Transforming Health and Care Systems (THCS): Horizon Europe co-funded partnership funding transnational research on health and care systems. Overlaps ERA4Health in member funders, joint-call structure, and health research focus areas.
• Innovative Health Initiative (IHI): EU Horizon Europe co-funded public-private partnership in health. Both IHI and ERA4Health pool EU and industry/member funding to coordinate transnational health research programmes across European consortia.
• European Partnership on Pandemic Preparedness: Co-funded Horizon Europe partnership coordinating pandemic-related research funding across European member states. Same governance and funding-pooling architecture as ERA4Health.
• European & Developing Countries Clinical Trials Partnership (EDCTP3): EU co-funded partnership under Horizon Europe supporting clinical trials, including multi-country studies. Closely mirrors ERA4Health's IICS function and transnational clinical research funding model.
• GARDP (Global Antibiotic R&D Partnership): Product Development Partnership coordinating R&D funding and clinical trials for new antibiotics. Comparable model of pooling public and philanthropic funding to run joint transnational calls and clinical studies.

Emerging players

• FIND (Foundation for Innovative New Diagnostics): Global non-profit coordinating diagnostic R&D and clinical evaluation across countries. Operates a similar pooled-funding model for transnational health research with comparable governance structures.
• Drugs for Neglected Diseases initiative (DNDi): Non-profit R&D organisation coordinating multi-country clinical studies through pooled public and philanthropic funding. Shares the partnership-driven, joint-call approach to transnational health research.

Broad incumbents

• EIT Health: EU-funded knowledge and innovation community supporting health innovation across Europe. Operates at broader scope than ERA4Health (innovation + research) but shares the EU funding backbone and pan-European consortium model.
• Innovative Medicines Initiative (IMI): Predecessor programme to IHI; pooled EU and industry funding to coordinate large-scale collaborative health research across European consortia. Direct historical analogue to ERA4Health's co-funding model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ERA4Health_EU
• LinkedInlinkedin.com/company/era4health

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ERA4Health